Efficacy and safety of 40 mg or 60 mg duloxetine in J apanese adults with diabetic neuropathic pain: Results from a randomized, 52‐week, open‐label study-Reference-Cited by-同舟云学术

Efficacy and safety of 40 mg or 60 mg duloxetine in J apanese adults with diabetic neuropathic pain: Results from a randomized, 52‐week, open‐label study

Published:2015-05-18 Issue:1 Volume:7 Page:100-108
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Invest

Author:

Yasuda Hitoshi¹,Hotta Nigishi²,Kasuga Masato³,Kashiwagi Atsunori⁴,Kawamori Ryuzo⁵,Yamada Tadaaki⁶,Baba Yuko⁶,Alev Levent⁷,Nakajo Ko⁷

Affiliation:

1. Faculty of Public Health Nursing Shiga University of Medical Science Shiga Japan

2. Japan Labor Health and Welfare Organization Chubu Rosai Hospital Nagoya Japan

3. Research Institute National Center for Global Health and Medicine Tokyo Japan

4. Kusatsu General Hospital Shiga Japan

5. Department of Medicine, Metabolism & Endocrinology Juntendo University Graduate School of Medicine Tokyo Japan

6. Shionogi & Co., Ltd. Osaka Japan

7. Lilly Research Laboratories Eli Lilly Japan K.K. Kobe Japan

Funder

Shionogi

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.12361

Reference33 articles.

1. Epidemiology, Public Health Burden, and Treatment of Diabetic Peripheral Neuropathic Pain: A Review

2. Diabetic dyslipidaemia in Asian populations in the Western Pacific Region: What we know and don’t know

3. Global Prevalence of Diabetes

4. Current status of neuropathic pain treatment in Japan and scope in future – proposal from the consensus conference of specialists;Hanaoka K;Pain Clinic,2009

5. A Review of the Epidemiology of Painful Diabetic Peripheral Neuropathy, Postherpetic Neuralgia, and Less Commonly Studied Neuropathic Pain Conditions

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Duloxetine versus Other Therapeutic Modalities in Patients with Diabetic Neuropathic Pain: A Systematic Review and Meta-Analysis;Pharmaceuticals;2024-06-28

2. Efficacy and safety of duloxetine in painful diabetic peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials;Systematic Reviews;2023-03-21

3. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update;Endocrine Practice;2022-10

4. Symptom-based pharmacotherapy for neuropathic pain related to spinal disorders: results from a patient-based assessment;Scientific Reports;2022-05-03

5. Role of duloxetine in neuropathic pain: A clinical impact, mechanism, challenges in formulation development to safety concern;Research Journal of Pharmacy and Technology;2022-04-23